As of the 9th of February 2019, pharmaceutical dispensers will be required to verify and decommission prescription medications under the European Union’s Falsified Medicines Directive (EU FMD).
To do so, dispensers will need to connect to their country’s National Medicines Verification System (NMVS), which in turn is connected to the European Medicines Verification System (EMVS), also known as the European Hub. The EMVS will receive a Unique Identifier (UI) number from the manufacturer for each prescription medicine to be sold within the European Union and act as a “router” to distribute them to the appropriate NMVS.
As solution providers, we are happy to guide you through the following steps to connect to your NMVS and achieve immediate EU FMD compliance.
1. Go to your country’s NMVS website and register your pharmacy. The following information will usually be asked:
2. After you complete the form, the NMVS will perform a legitimacy check.
3. The administrator will then receive two emails: one from the registration desk of the NMVS to provide the information (see below) to connect your EU FMD system to the NMVS, and the other from the EMVO, containing a link to complete your registration. Note: Arvato will provide additional information as shown below.
Once you have registered your healthcare institution with your NMVS, you will be able to provide us with the following information. This information is necessary for OPTEL to configure your verification and decommissioning solution, OPTEL Certa™ Software.
For both Arvato and Solidsoft:
Additional information for Arvato only:
Find your country’s NMVS page below: